
25 Aug 2022
Faron Pharmaceuticals (Buy) - 1H22: clinical progression for an exciting oncology asset
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Faron Pharmaceuticals (Buy) - 1H22: clinical progression for an exciting oncology asset
Faron Pharmaceuticals Oy (FARN:LON) | 202 0 0.0% | Mkt Cap: 226.7m
- Published:
25 Aug 2022 -
Author:
Miles Dixon -
Pages:
5 -